Skin Disease
11
2
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
The Skin Microbiota in Skin Disease and Eczema
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Dynamics of Dysbiosis in the Skin and Gut Microbiome of Burn Patients
Visible Light Study
Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine
Structure of the Herpes Simplex Virus Receptor
A Study to Document the Effect of Petrolatum on Innate Immune Responses in the Skin
Washing Without Water: Cost-effectiveness of a Rapidly Spreading Nursing Intervention in Bedridden Patients'
Evaluation of Tele-expertise for Inmates With a Dermatological Lesion
Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels
A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema